<- Back to digest

JSES - 2026-10-20 - Journal Article

Development and Validation of the Shoulder Arthroplasty Risk of Non-Home Discharge (SHORD) Score: A Risk Stratification Model for Non-Home Discharge Following Primary Total Shoulder Arthroplasty.

Phadke RA, Salman SG, Khawaja SR, Fiedler B, Rana A, Hussain ZB, Garrigues GE, Edwards TB

retrospective cohortLOE IIIn = 29,382N/A

Topics

shoulder elbow
PMID: 42901235DOI: 10.1016/j.jse.2026.10.017View on PubMed ->

Key Takeaway

The SHORD Score, a 16-variable preoperative integer-point tool, predicts non-home discharge after primary TSA with an AUROC of 0.816 and a 20-fold risk gradient (0.4% to 20.3%) across risk strata.

Summary Depth

Choose how much analysis to show on this article page.

Summary

This study asked whether a purely preoperative scoring tool could accurately predict non-home discharge (NHD) after primary TSA, using ACS-NSQIP data from 2016–2021 split into derivation and held-out validation cohorts. Sixteen independent predictors were identified by multivariable logistic regression and converted to integer points; the strongest predictors were age ≥85, transfer from acute care, ASA class 4, dependent functional status, and preoperative non-home residence. The SHORD Score achieved AUROC 0.816 in validation, outperformed all comparators including mFI-5, ASA class, RAI, and NSQIP morbidity probability (all DeLong P<.001), with excellent calibration (slope 0.96, Brier score 0.057).

Key Limitation

The score is internally validated only within NSQIP, which captures 30-day outcomes and lacks granular social determinants of health, insurance status, and implant type (anatomic vs. reverse), limiting generalizability and mechanistic interpretation.

Original Abstract

BACKGROUND

Non-home discharge (NHD) after total shoulder arthroplasty (TSA) increases cost, complications, and readmission, yet most existing risk tools depend on postoperative data or are not built to directly estimate the risk of this outcome. We developed and validated the Shoulder Arthroplasty Risk of Non-home Discharge (SHORD) Score, a purely preoperative bedside tool.

METHODS

We carried out a retrospective prognostic model development and validation study of 29,382 patients undergoing primary TSA in the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP, 2016 to 2021). Patients were split into a derivation (two-thirds) and a held-out validation (one-third) cohort. Preoperative candidate predictors were screened by univariate logistic regression, assessed for collinearity, and entered into multivariable logistic regression; independent predictors were converted to integer points to form the SHORD Score. Discrimination (area under the receiver operating characteristic curve [AUROC]), calibration, and classification were assessed in validation and compared with the 5-item modified frailty index (mFI-5), American Society of Anesthesiologists (ASA) class, age, the Risk Analysis Index (RAI), and the NSQIP morbidity probability using the DeLong test. Sensitivity analyses addressed acute proximal humerus fracture, baseline non-home residence, missing albumin, and dyspnea.

RESULTS

NHD occurred in 2,057 patients (7.0%). 16 independent predictors formed the score, the strongest being age 85 years or older, transfer from acute care, ASA class 4, dependent functional status, and preoperative non-home residence. In validation, the SHORD Score achieved an AUROC of 0.816 (95% confidence interval 0.802 to 0.830) with excellent calibration (calibration slope 0.96; Brier score 0.057). It significantly outperformed every comparator (all DeLong P < .001) and produced a marked gradient exceeding 20-fold, from 0.4% in the lowest risk group to 20.3% in the highest. Discrimination was similar across subgroups and sensitivity analyses, including after excluding the 5.7% of patients with acute proximal humerus fracture (AUROC 0.811).

CONCLUSION

The SHORD Score is an internally validated, preoperative tool whose score is associated with non-home discharge after shoulder arthroplasty and uses only admission-day variables, which may support early discharge planning and resource allocation. External and prospective validation are warranted.